BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 28130349)

  • 21. Puberty as a risk factor for less favorable visual outcome in idiopathic intracranial hypertension.
    Stiebel-Kalish H; Kalish Y; Lusky M; Gaton DD; Ehrlich R; Shuper A
    Am J Ophthalmol; 2006 Aug; 142(2):279-83. PubMed ID: 16876509
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Photographic Reading Center of the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT): Methods and Baseline Results.
    Fischer WS; Wall M; McDermott MP; Kupersmith MJ; Feldon SE;
    Invest Ophthalmol Vis Sci; 2015 May; 56(5):3292-303. PubMed ID: 26024112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Detection of nerve fiber atrophy in apparently effectively treated papilledema in idiopathic intracranial hypertension.
    Laemmer R; Heckmann JG; Mardin CY; Schwab S; Laemmer AB
    Graefes Arch Clin Exp Ophthalmol; 2010 Dec; 248(12):1787-93. PubMed ID: 20677009
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Short-term Optic Disc Cupping Reversal in a Patient With Mild Juvenile Open-angle Glaucoma Due to Early Idiopathic Intracranial Hypertension.
    Umfress AC; Mawn LA; Joos KM
    J Glaucoma; 2019 Apr; 28(4):e53-e57. PubMed ID: 30531192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinal and Choroidal Folds in Papilledema.
    Sibony PA; Kupersmith MJ; Feldon SE; Wang JK; Garvin M;
    Invest Ophthalmol Vis Sci; 2015 Sep; 56(10):5670-80. PubMed ID: 26335066
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
    Wall M; Johnson CA; Cello KE; Zamba KD; McDermott MP; Keltner JL;
    Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):805-12. PubMed ID: 26934136
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
    Kattah JC; Pula JH; Mejico LJ; McDermott MP; Kupersmith MJ; Wall M
    J Neurol; 2015 Oct; 262(10):2271-4. PubMed ID: 26159101
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Retinal Manifestations of Idiopathic Intracranial Hypertension.
    Nichani P; Micieli JA
    Ophthalmol Retina; 2021 May; 5(5):429-437. PubMed ID: 32860958
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sleep apnea and intracranial hypertension in men.
    Lee AG; Golnik K; Kardon R; Wall M; Eggenberger E; Yedavally S
    Ophthalmology; 2002 Mar; 109(3):482-5. PubMed ID: 11874748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The idiopathic intracranial hypertension treatment trial: design considerations and methods.
    Friedman DI; McDermott MP; Kieburtz K; Kupersmith M; Stoutenburg A; Keltner JL; Feldon SE; Schron E; Corbett JJ; Wall M;
    J Neuroophthalmol; 2014 Jun; 34(2):107-17. PubMed ID: 24739993
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Optic disc hemorrhage may be associated with retinal nerve fiber loss in otherwise normal eyes.
    Jeoung JW; Park KH; Kim JM; Kang SH; Kang JH; Kim TW; Kim DM
    Ophthalmology; 2008 Dec; 115(12):2132-40. PubMed ID: 19041474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Idiopathic Intracranial Hypertension Treatment Trial: A Review of the Outcomes.
    Smith SV; Friedman DI
    Headache; 2017 Sep; 57(8):1303-1310. PubMed ID: 28758206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visual Field Mean Deviation at Diagnosis of Idiopathic Intracranial Hypertension Predicts Visual Outcome.
    Mikkilineni S; Trobe JD; Cornblath WT; De Lott L
    J Neuroophthalmol; 2019 Jun; 39(2):186-190. PubMed ID: 30153119
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation of structural retinal nerve fibre layer parameters and functional measures using Heidelberg Retinal Tomography and Spectralis spectral domain optical coherence tomography at different levels of glaucoma severity.
    Leaney J; Healey PR; Lee M; Graham SL
    Clin Exp Ophthalmol; 2012 Nov; 40(8):802-12. PubMed ID: 22594488
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation between optic disc drusen and optic disc oedema using fundus photography.
    Lee KM; Woo SJ; Hwang JM
    Acta Ophthalmol; 2017 Jun; 95(4):e329-e335. PubMed ID: 28084042
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Superonasal Transconjunctival Optic Nerve Sheath Decompression: A Simplified Technique for Safe and Efficient Decompression.
    Melson AT; Warmath JD; Moreau A; Farris BK
    J Neuroophthalmol; 2021 Mar; 41(1):e16-e21. PubMed ID: 32141981
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
    Albrecht P; Blasberg C; Ringelstein M; Müller AK; Finis D; Guthoff R; Kadas EM; Lagreze W; Aktas O; Hartung HP; Paul F; Brandt AU; Methner A
    J Neurol; 2017 Jul; 264(7):1370-1380. PubMed ID: 28584914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optic disc haemorrhages and vascular abnormalities in a glaucoma population.
    Barry CJ; Cooper RL; Eikelboom RH
    Aust N Z J Ophthalmol; 1997 May; 25(2):137-44. PubMed ID: 9267600
    [TBL] [Abstract][Full Text] [Related]  

  • 39. External lumbar drainage in progressive pediatric idiopathic intracranial hypertension.
    Dotan G; Hadar Cohen N; Qureshi HM; Shapira Rootman M; Nevo Y; Kershenovich A
    J Neurosurg Pediatr; 2021 Jul; 28(4):490-496. PubMed ID: 34271543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Swelling of Atrophic Optic Discs in Idiopathic Intracranial Hypertension.
    Xie JS; Donaldson L; Margolin EA
    J Neuroophthalmol; 2024 Jun; 44(2):212-218. PubMed ID: 37436882
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.